array:23 [
  "pii" => "S2341287916300862"
  "issn" => "23412879"
  "doi" => "10.1016/j.anpede.2016.05.001"
  "estado" => "S300"
  "fechaPublicacion" => "2016-08-01"
  "aid" => "2118"
  "copyright" => "Asociación Española de Pediatría"
  "copyrightAnyo" => "2016"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "sco"
  "cita" => "An Pediatr (Barc). 2016;85:59-60"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 1876
    "formatos" => array:3 [
      "EPUB" => 119
      "HTML" => 1313
      "PDF" => 444
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S1695403316302004"
      "issn" => "16954033"
      "doi" => "10.1016/j.anpedi.2016.05.007"
      "estado" => "S300"
      "fechaPublicacion" => "2016-08-01"
      "aid" => "2118"
      "copyright" => "Asociación Española de Pediatría"
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "sco"
      "cita" => "An Pediatr (Barc). 2016;85:59-60"
      "abierto" => array:3 [
        "ES" => false
        "ES2" => false
        "LATM" => false
      ]
      "gratuito" => false
      "lecturas" => array:2 [
        "total" => 11854
        "formatos" => array:3 [
          "EPUB" => 125
          "HTML" => 10058
          "PDF" => 1671
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
        "titulo" => "La oncolog&#237;a pedi&#225;trica&#58; pasado&#44; presente y futuro"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "59"
            "paginaFinal" => "60"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Paediatric oncology&#58; Past&#44; present and future"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Rafael Fern&#225;ndez-Delgado"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "Rafael"
                "apellidos" => "Fern&#225;ndez-Delgado"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2341287916300862"
          "doi" => "10.1016/j.anpede.2016.05.001"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287916300862?idApp=UINPBA00005H"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403316302004?idApp=UINPBA00005H"
      "url" => "/16954033/0000008500000002/v1_201607230206/S1695403316302004/v1_201607230206/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S2341287915002239"
    "issn" => "23412879"
    "doi" => "10.1016/j.anpede.2015.07.020"
    "estado" => "S300"
    "fechaPublicacion" => "2016-08-01"
    "aid" => "1986"
    "copyright" => "Asociaci&#243;n Espa&#241;ola de Pediatr&#237;a"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "An Pediatr &#40;Barc&#41;. 2016;85:61-9"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 2562
      "formatos" => array:3 [
        "EPUB" => 171
        "HTML" => 1909
        "PDF" => 482
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
      "titulo" => "Critically ill pediatric hemato-oncology patient&#58; What we do is what we should do&#63;"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "61"
          "paginaFinal" => "69"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Paciente cr&#243;nico oncohematol&#243;gico&#44; &#191;hacemos lo que deber&#237;amos hacer&#63;"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0015"
          "etiqueta" => "Figure 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 3166
              "Ancho" => 2644
              "Tamanyo" => 252226
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">&#40;a&#41; Do you use HFOV if refractory hypoxemia and&#47;or hypoventilation to conventional mechanical ventilation&#63; &#40;b&#41; Respiratory management if refractory hypoxemia or hypoventilation to conventional mechanical ventilation&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Alberto Garc&#237;a-Salido, Montserrat Nieto-Moro, Mar&#237;a Isabel Iglesias-Bouzas, Marta Gonz&#225;lez-Vicent, Ana Serrano-Gonz&#225;lez, Juan Casado-Flores"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Alberto"
              "apellidos" => "Garc&#237;a-Salido"
            ]
            1 => array:2 [
              "nombre" => "Montserrat"
              "apellidos" => "Nieto-Moro"
            ]
            2 => array:2 [
              "nombre" => "Mar&#237;a Isabel"
              "apellidos" => "Iglesias-Bouzas"
            ]
            3 => array:2 [
              "nombre" => "Marta"
              "apellidos" => "Gonz&#225;lez-Vicent"
            ]
            4 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "Serrano-Gonz&#225;lez"
            ]
            5 => array:2 [
              "nombre" => "Juan"
              "apellidos" => "Casado-Flores"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287915002239?idApp=UINPBA00005H"
    "url" => "/23412879/0000008500000002/v1_201607230332/S2341287915002239/v1_201607230332/en/main.assets"
  ]
  "en" => array:12 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
    "titulo" => "Paediatric oncology&#58; Past&#44; present and future"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "59"
        "paginaFinal" => "60"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Rafael Fern&#225;ndez-Delgado"
        "autores" => array:1 [
          0 => array:4 [
            "nombre" => "Rafael"
            "apellidos" => "Fern&#225;ndez-Delgado"
            "email" => array:1 [
              0 => "Rafael&#46;Fdez-delgado&#64;uv&#46;es"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Secci&#243;n de Oncohematolog&#237;a Pedi&#225;trica&#44; Hospital Cl&#237;nico Universitario&#44; INCLIVA&#44; Valencia&#44; Spain"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Universitat de Valencia&#44; Valencia&#44; Spain"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "La oncolog&#237;a pedi&#225;trica&#58; pasado&#44; presente y futuro"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Childhood cancer treatment has improved spectacularly in the last 25 years&#44; with an increase in overall cure rates from 20&#37; to 30&#37; in the late 1970s to over 75&#37; today&#46; However&#44; we must not fall into complacency and assume that the problem is largely solved&#46; Cancer is one of the main causes of mortality in the paediatric age group and there is considerable room for improvement&#44; which society must address&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">The development of the various types of treatment over time reveals very marked differences between past and present&#44; and above all it allows us to foresee a future in which new diagnostic and therapeutic approaches will succeed in increasing survival and may offer curative treatments for those diseases where they do not currently exist&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">The introduction of chemotherapy&#44; in the middle of the last century&#44; ushered in an era of improvement in the prognosis of malignant diseases in children&#46; A number of drugs were used with varying degrees of success in a range of cancer types&#44; generally in empirical combinations&#44; achieving partial or total remission and increased survival in certain tumours&#46; The diagnostic tools used were primarily derived from conventional radiology&#46; Cytological and histological studies&#44; the basis of diagnosis&#44; gradually enabled us to get to know the morphological structure of the diseased tissue&#44; and subsequently its functional characteristics&#44; through the use of more suitable staining techniques&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">The initial successes&#44; given the small number of patients&#44; highlighted the need to organise cooperative groups that would enable prospective studies to be performed to discover the efficacy of the various treatments&#46; The establishment of national and international Paediatric Oncology or Oncohaematology working groups made it possible to create specific institutions for collecting data and organising studies to increase knowledge of the various diseases&#46; Thus the Spanish Paediatric Oncology Society was found in 1977&#44; although national and international meetings on the subject had been taking place since 1969&#46; The establishment of the current Spanish Register of Childhood Tumours in 1979 has provided us&#44; since then&#44; with a firm structure for knowledge of the specific situation of childhood cancer in Spain&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">Currently&#44; cure rates of over 85&#8211;90&#37; are attained in some diseases &#40;lymphoblastic leukaemias&#44; lymphomas&#44; Hodgkin&#39;s disease&#44; Wilm&#39;s tumour&#44; etc&#46;&#41;&#46; Other groups of diseases&#44; however&#44; do not show the same therapeutic success and have a poor initial prognosis &#40;tumours of the central nervous system&#44; bone tumours&#44; mesenchymal tumours&#44; etc&#46;&#41;&#46; In both groups there is potential for improvement&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">In the former&#44; the aim must be to limit early and late toxicity by &#8220;de-escalating&#8221; the treatment&#44; making it more comfortable and caring&#44; prioritising outpatient treatment and improving palliative care &#40;pain&#44; infections&#44; digestive toxicity&#41;&#46; It is not just a matter of increasing the survival rate but of making a qualitative leap&#44; improving the quality of life for patients and survivors and reducing the sequelae of the disease and its treatment&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">In the second group the aim lies in making better use of the means available and finding new therapeutic tools to enable us to improve the prognosis&#46; In this connection&#44; we have known since the end of the last century that cells in probably all malignant diseases show specific molecular alterations that can be therapeutic targets for drugs that act preferentially on the tumour and not on normal tissues&#44; reducing toxicity&#46; Examples of this type of drug are imatinib&#44; which has been used for years in chronic myeloid leukaemia&#44; but also dasatinib&#44; ibrutinib&#44; crizotinib and others&#44; some of which are still in the experimental stage&#46; This therapeutic strategy looks set to occupy an important place in the future of childhood cancer treatment&#46; As well as these generic principles&#44; the future of treatment depends on exact knowledge of the specific molecular alterations of each tumour individually and how these alterations develop in the course of treatment&#46; For this purpose the exome of the tumour cells in each patient needs to be sequenced&#44; drawing the molecular footprint and adapting the treatment to the specific alterations&#46; This type of therapeutic approach&#44; known as &#8220;precision medicine&#8221;&#44; must be applied at least to patients with more complex diseases&#46; Epigenetics is also being studied as a form of diagnostic and therapeutic approach&#44; as the study by Boloix et al&#46; included in this issue of <span class="elsevierStyleItalic">Anales</span> shows&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">Immunotherapy has not been lagging behind&#46; From non-specific stimulation of the immune system by continuous administration of BCG&#44; which has been used for over 40 years&#44; to current approaches to CAR-T technology&#44; there has been a succession of effective treatments&#44; prominent among which are monoclonal antibodies directed against antigens expressed by tumour cells&#46; Experience with anti-CD20&#44; anti-CD33 and others has shown their efficacy in the treatment of lymphoid or myeloid proliferations&#46; More recently the possibility of engineering T lymphocytes to produce a chimeric receptor &#40;chimeric antigen receptor &#91;CAR&#93;&#41;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> for an antigen expressed by tumour cells and thereby provoking a cellular immune response&#44; killing tumour cells&#44; has opened up a new therapeutic strategy for diseases considered resistant to conventional treatments&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">These advances have been accompanied by a remarkable improvement in diagnostic possibilities&#44; from imaging to cell recognition techniques&#44; many of which are within reach of most hospitals&#44; even though centralised review becomes necessary in all cooperative studies&#46; Magnetic resonance has progressively improved the precision of normal and pathological images of the body and is currently accompanied by isotopic methods using radioactive glucose that make it possible to determine the metabolic activity of tissues&#44; differentiating between the normal and the pathological and constituting a very valuable tool in extension studies&#46; This technique &#40;positron emission tomography &#91;PET&#93;&#41; has already proved valuable in some paediatric tumours and its definitive application to other diseases is under consideration&#46; On the other hand&#44; analysis of minimal disseminated disease in bone marrow and peripheral blood<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> using molecular biology techniques enables us to obtain more accurate knowledge of the extent of the disease and to consider as generalised an alteration that might have been defined as localised using conventional methods and therefore treated suboptimally&#46; This technique is directly linked to what has been called &#8220;liquid biopsy&#8221;&#44; which involves looking for circulating DNA from tumour cells using PCR techniques&#44; which clearly improves diagnostic precision&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">All this has changed the perception of paediatricians who do not specialise in the care of children with cancer&#46; A paediatric cancer patient is not a doomed invalid but someone with a life to be fought for&#44; and the intercurrencies that arise during the course of the illness and its treatment are now a therapeutic objective&#44; whereas until a few years ago they were regarded as a regrettable complication&#46; The majority of Paediatric Intensive Care Units express this view&#44; according to the survey presented by Garc&#237;a-Salido et al&#46;<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">By the same line of argument&#44; these possibilities for improvement cannot be applied exclusively to select populations&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a> We must not forget that the main objective of paediatric oncology is to try to ensure that no child dies of cancer&#44; that is&#44; to cure the highest possible number of children suffering from malignant diseases&#46; Although medicine is increasingly capable of defining the prognostic factors that influence a patient&#39;s chances of survival&#44; as paediatric oncologists we know that the main prognostic factor in a given community is the financial investment society is able to assign to the diagnosis and treatment of cancer in children&#46; This investment must be equitably distributed&#44; so as to give children from all geographical areas access to the best care&#46; While remaining aware of the need to stratify care management &#40;health care resources must be allocated sequentially to cover the needs of an entire geographical area&#41;&#44; associations of parents and relatives of children with cancer must be firm in demanding equal quality&#46; Only on this basis will we&#44; as doctors&#44; and society at large keep faith with the people we are devoted to&#58; children suffering from malignant diseases&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Fern&#225;ndez-Delgado Cerd&#225; R&#46; La oncolog&#237;a pedi&#225;trica&#58; pasado&#44; presente y futuro&#46; An Pediatr &#40;Barc&#41;&#46; 2016&#59;85&#58;59&#8211;60&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nuevas estrategias terap&#233;uticas para el neuroblastoma basadas en los micro-RNA"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Boloix"
                            1 => "L&#46; Par&#237;s-Coderch"
                            2 => "A&#46; Soriano"
                            3 => "J&#46; Roma"
                            4 => "S&#46; Gallego"
                            5 => "J&#46; S&#225;nchez de Toledo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "An Pediatr &#40;Barc&#41;"
                        "fecha" => "2016"
                        "volumen" => "85"
                        "paginaInicial" => "109&#46;e1"
                        "paginaFinal" => "109&#46;e6"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Driving CAR-T cells forward"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "H&#46;J&#46; Jackson"
                            1 => "S&#46; Rafiq"
                            2 => "R&#46;J&#46; Brentjens"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/nrclinonc.2016.36"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat Rev Clin Oncol"
                        "fecha" => "2016"
                        "volumen" => "13"
                        "paginaInicial" => "370"
                        "paginaFinal" => "383"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27000958"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Minimal disseminated disease in pediatric non-Hodgkin lymphoma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "L&#46; Mussolin"
                            1 => "A&#46; Rosolen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Carcinog Mutagen"
                        "fecha" => "2013"
                        "volumen" => "5"
                        "paginaInicial" => "1"
                        "paginaFinal" => "2"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Paciente cr&#237;tico onco-hematol&#243;gico&#46; &#191;Hacemos lo que deber&#237;amos hacer&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46; Garc&#237;a-Salido"
                            1 => "M&#46; Nieto-Moro"
                            2 => "M&#46;I&#46; Iglesias-Bouzas"
                            3 => "M&#46; Gonz&#225;lez-Vicent"
                            4 => "A&#46; Serrano-Gonz&#225;lez"
                            5 => "J&#46; Casado-Flores"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "An Pediatr"
                        "fecha" => "2016"
                        "volumen" => "85"
                        "paginaInicial" => "61"
                        "paginaFinal" => "69"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "European survey on standards of care in pediatric oncology centres"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;R&#46; Kowalczyk"
                            1 => "M&#46; Samardakiewicz"
                            2 => "K&#46; Pritchard-Jones"
                            3 => "R&#46; Ladenstein"
                            4 => "S&#46; Essiaf"
                            5 => "E&#46; Fitzgerald"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ejca.2016.03.073"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Cancer"
                        "fecha" => "2016"
                        "volumen" => "61"
                        "paginaInicial" => "11"
                        "paginaFinal" => "19"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27131152"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/23412879/0000008500000002/v1_201607230332/S2341287916300862/v1_201607230332/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "25501"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Editorial"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/23412879/0000008500000002/v1_201607230332/S2341287916300862/v1_201607230332/en/main.pdf?idApp=UINPBA00005H&text.app=https://analesdepediatria.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287916300862?idApp=UINPBA00005H"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Editorial
Paediatric oncology: Past, present and future
La oncología pediátrica: pasado, presente y futuro
Rafael Fernández-Delgadoa,b
a Sección de Oncohematología Pediátrica, Hospital Clínico Universitario, INCLIVA, Valencia, Spain
b Universitat de Valencia, Valencia, Spain
Read
6711
Times
was read the article
2249
Total PDF
4462
Total HTML
Share statistics
 array:23 [
  "pii" => "S2341287916300862"
  "issn" => "23412879"
  "doi" => "10.1016/j.anpede.2016.05.001"
  "estado" => "S300"
  "fechaPublicacion" => "2016-08-01"
  "aid" => "2118"
  "copyright" => "Asociaci&#243;n Espa&#241;ola de Pediatr&#237;a"
  "copyrightAnyo" => "2016"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "sco"
  "cita" => "An Pediatr &#40;Barc&#41;. 2016;85:59-60"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 1876
    "formatos" => array:3 [
      "EPUB" => 119
      "HTML" => 1313
      "PDF" => 444
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S1695403316302004"
      "issn" => "16954033"
      "doi" => "10.1016/j.anpedi.2016.05.007"
      "estado" => "S300"
      "fechaPublicacion" => "2016-08-01"
      "aid" => "2118"
      "copyright" => "Asociaci&#243;n Espa&#241;ola de Pediatr&#237;a"
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "sco"
      "cita" => "An Pediatr &#40;Barc&#41;. 2016;85:59-60"
      "abierto" => array:3 [
        "ES" => false
        "ES2" => false
        "LATM" => false
      ]
      "gratuito" => false
      "lecturas" => array:2 [
        "total" => 11854
        "formatos" => array:3 [
          "EPUB" => 125
          "HTML" => 10058
          "PDF" => 1671
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
        "titulo" => "La oncolog&#237;a pedi&#225;trica&#58; pasado&#44; presente y futuro"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "59"
            "paginaFinal" => "60"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Paediatric oncology&#58; Past&#44; present and future"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Rafael Fern&#225;ndez-Delgado"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "Rafael"
                "apellidos" => "Fern&#225;ndez-Delgado"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2341287916300862"
          "doi" => "10.1016/j.anpede.2016.05.001"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287916300862?idApp=UINPBA00005H"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403316302004?idApp=UINPBA00005H"
      "url" => "/16954033/0000008500000002/v1_201607230206/S1695403316302004/v1_201607230206/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S2341287915002239"
    "issn" => "23412879"
    "doi" => "10.1016/j.anpede.2015.07.020"
    "estado" => "S300"
    "fechaPublicacion" => "2016-08-01"
    "aid" => "1986"
    "copyright" => "Asociaci&#243;n Espa&#241;ola de Pediatr&#237;a"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "An Pediatr &#40;Barc&#41;. 2016;85:61-9"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 2562
      "formatos" => array:3 [
        "EPUB" => 171
        "HTML" => 1909
        "PDF" => 482
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
      "titulo" => "Critically ill pediatric hemato-oncology patient&#58; What we do is what we should do&#63;"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "61"
          "paginaFinal" => "69"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Paciente cr&#243;nico oncohematol&#243;gico&#44; &#191;hacemos lo que deber&#237;amos hacer&#63;"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0015"
          "etiqueta" => "Figure 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 3166
              "Ancho" => 2644
              "Tamanyo" => 252226
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">&#40;a&#41; Do you use HFOV if refractory hypoxemia and&#47;or hypoventilation to conventional mechanical ventilation&#63; &#40;b&#41; Respiratory management if refractory hypoxemia or hypoventilation to conventional mechanical ventilation&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Alberto Garc&#237;a-Salido, Montserrat Nieto-Moro, Mar&#237;a Isabel Iglesias-Bouzas, Marta Gonz&#225;lez-Vicent, Ana Serrano-Gonz&#225;lez, Juan Casado-Flores"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Alberto"
              "apellidos" => "Garc&#237;a-Salido"
            ]
            1 => array:2 [
              "nombre" => "Montserrat"
              "apellidos" => "Nieto-Moro"
            ]
            2 => array:2 [
              "nombre" => "Mar&#237;a Isabel"
              "apellidos" => "Iglesias-Bouzas"
            ]
            3 => array:2 [
              "nombre" => "Marta"
              "apellidos" => "Gonz&#225;lez-Vicent"
            ]
            4 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "Serrano-Gonz&#225;lez"
            ]
            5 => array:2 [
              "nombre" => "Juan"
              "apellidos" => "Casado-Flores"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287915002239?idApp=UINPBA00005H"
    "url" => "/23412879/0000008500000002/v1_201607230332/S2341287915002239/v1_201607230332/en/main.assets"
  ]
  "en" => array:12 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
    "titulo" => "Paediatric oncology&#58; Past&#44; present and future"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "59"
        "paginaFinal" => "60"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Rafael Fern&#225;ndez-Delgado"
        "autores" => array:1 [
          0 => array:4 [
            "nombre" => "Rafael"
            "apellidos" => "Fern&#225;ndez-Delgado"
            "email" => array:1 [
              0 => "Rafael&#46;Fdez-delgado&#64;uv&#46;es"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Secci&#243;n de Oncohematolog&#237;a Pedi&#225;trica&#44; Hospital Cl&#237;nico Universitario&#44; INCLIVA&#44; Valencia&#44; Spain"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Universitat de Valencia&#44; Valencia&#44; Spain"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "La oncolog&#237;a pedi&#225;trica&#58; pasado&#44; presente y futuro"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Childhood cancer treatment has improved spectacularly in the last 25 years&#44; with an increase in overall cure rates from 20&#37; to 30&#37; in the late 1970s to over 75&#37; today&#46; However&#44; we must not fall into complacency and assume that the problem is largely solved&#46; Cancer is one of the main causes of mortality in the paediatric age group and there is considerable room for improvement&#44; which society must address&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">The development of the various types of treatment over time reveals very marked differences between past and present&#44; and above all it allows us to foresee a future in which new diagnostic and therapeutic approaches will succeed in increasing survival and may offer curative treatments for those diseases where they do not currently exist&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">The introduction of chemotherapy&#44; in the middle of the last century&#44; ushered in an era of improvement in the prognosis of malignant diseases in children&#46; A number of drugs were used with varying degrees of success in a range of cancer types&#44; generally in empirical combinations&#44; achieving partial or total remission and increased survival in certain tumours&#46; The diagnostic tools used were primarily derived from conventional radiology&#46; Cytological and histological studies&#44; the basis of diagnosis&#44; gradually enabled us to get to know the morphological structure of the diseased tissue&#44; and subsequently its functional characteristics&#44; through the use of more suitable staining techniques&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">The initial successes&#44; given the small number of patients&#44; highlighted the need to organise cooperative groups that would enable prospective studies to be performed to discover the efficacy of the various treatments&#46; The establishment of national and international Paediatric Oncology or Oncohaematology working groups made it possible to create specific institutions for collecting data and organising studies to increase knowledge of the various diseases&#46; Thus the Spanish Paediatric Oncology Society was found in 1977&#44; although national and international meetings on the subject had been taking place since 1969&#46; The establishment of the current Spanish Register of Childhood Tumours in 1979 has provided us&#44; since then&#44; with a firm structure for knowledge of the specific situation of childhood cancer in Spain&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">Currently&#44; cure rates of over 85&#8211;90&#37; are attained in some diseases &#40;lymphoblastic leukaemias&#44; lymphomas&#44; Hodgkin&#39;s disease&#44; Wilm&#39;s tumour&#44; etc&#46;&#41;&#46; Other groups of diseases&#44; however&#44; do not show the same therapeutic success and have a poor initial prognosis &#40;tumours of the central nervous system&#44; bone tumours&#44; mesenchymal tumours&#44; etc&#46;&#41;&#46; In both groups there is potential for improvement&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">In the former&#44; the aim must be to limit early and late toxicity by &#8220;de-escalating&#8221; the treatment&#44; making it more comfortable and caring&#44; prioritising outpatient treatment and improving palliative care &#40;pain&#44; infections&#44; digestive toxicity&#41;&#46; It is not just a matter of increasing the survival rate but of making a qualitative leap&#44; improving the quality of life for patients and survivors and reducing the sequelae of the disease and its treatment&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">In the second group the aim lies in making better use of the means available and finding new therapeutic tools to enable us to improve the prognosis&#46; In this connection&#44; we have known since the end of the last century that cells in probably all malignant diseases show specific molecular alterations that can be therapeutic targets for drugs that act preferentially on the tumour and not on normal tissues&#44; reducing toxicity&#46; Examples of this type of drug are imatinib&#44; which has been used for years in chronic myeloid leukaemia&#44; but also dasatinib&#44; ibrutinib&#44; crizotinib and others&#44; some of which are still in the experimental stage&#46; This therapeutic strategy looks set to occupy an important place in the future of childhood cancer treatment&#46; As well as these generic principles&#44; the future of treatment depends on exact knowledge of the specific molecular alterations of each tumour individually and how these alterations develop in the course of treatment&#46; For this purpose the exome of the tumour cells in each patient needs to be sequenced&#44; drawing the molecular footprint and adapting the treatment to the specific alterations&#46; This type of therapeutic approach&#44; known as &#8220;precision medicine&#8221;&#44; must be applied at least to patients with more complex diseases&#46; Epigenetics is also being studied as a form of diagnostic and therapeutic approach&#44; as the study by Boloix et al&#46; included in this issue of <span class="elsevierStyleItalic">Anales</span> shows&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">Immunotherapy has not been lagging behind&#46; From non-specific stimulation of the immune system by continuous administration of BCG&#44; which has been used for over 40 years&#44; to current approaches to CAR-T technology&#44; there has been a succession of effective treatments&#44; prominent among which are monoclonal antibodies directed against antigens expressed by tumour cells&#46; Experience with anti-CD20&#44; anti-CD33 and others has shown their efficacy in the treatment of lymphoid or myeloid proliferations&#46; More recently the possibility of engineering T lymphocytes to produce a chimeric receptor &#40;chimeric antigen receptor &#91;CAR&#93;&#41;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> for an antigen expressed by tumour cells and thereby provoking a cellular immune response&#44; killing tumour cells&#44; has opened up a new therapeutic strategy for diseases considered resistant to conventional treatments&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">These advances have been accompanied by a remarkable improvement in diagnostic possibilities&#44; from imaging to cell recognition techniques&#44; many of which are within reach of most hospitals&#44; even though centralised review becomes necessary in all cooperative studies&#46; Magnetic resonance has progressively improved the precision of normal and pathological images of the body and is currently accompanied by isotopic methods using radioactive glucose that make it possible to determine the metabolic activity of tissues&#44; differentiating between the normal and the pathological and constituting a very valuable tool in extension studies&#46; This technique &#40;positron emission tomography &#91;PET&#93;&#41; has already proved valuable in some paediatric tumours and its definitive application to other diseases is under consideration&#46; On the other hand&#44; analysis of minimal disseminated disease in bone marrow and peripheral blood<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> using molecular biology techniques enables us to obtain more accurate knowledge of the extent of the disease and to consider as generalised an alteration that might have been defined as localised using conventional methods and therefore treated suboptimally&#46; This technique is directly linked to what has been called &#8220;liquid biopsy&#8221;&#44; which involves looking for circulating DNA from tumour cells using PCR techniques&#44; which clearly improves diagnostic precision&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">All this has changed the perception of paediatricians who do not specialise in the care of children with cancer&#46; A paediatric cancer patient is not a doomed invalid but someone with a life to be fought for&#44; and the intercurrencies that arise during the course of the illness and its treatment are now a therapeutic objective&#44; whereas until a few years ago they were regarded as a regrettable complication&#46; The majority of Paediatric Intensive Care Units express this view&#44; according to the survey presented by Garc&#237;a-Salido et al&#46;<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">By the same line of argument&#44; these possibilities for improvement cannot be applied exclusively to select populations&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a> We must not forget that the main objective of paediatric oncology is to try to ensure that no child dies of cancer&#44; that is&#44; to cure the highest possible number of children suffering from malignant diseases&#46; Although medicine is increasingly capable of defining the prognostic factors that influence a patient&#39;s chances of survival&#44; as paediatric oncologists we know that the main prognostic factor in a given community is the financial investment society is able to assign to the diagnosis and treatment of cancer in children&#46; This investment must be equitably distributed&#44; so as to give children from all geographical areas access to the best care&#46; While remaining aware of the need to stratify care management &#40;health care resources must be allocated sequentially to cover the needs of an entire geographical area&#41;&#44; associations of parents and relatives of children with cancer must be firm in demanding equal quality&#46; Only on this basis will we&#44; as doctors&#44; and society at large keep faith with the people we are devoted to&#58; children suffering from malignant diseases&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Fern&#225;ndez-Delgado Cerd&#225; R&#46; La oncolog&#237;a pedi&#225;trica&#58; pasado&#44; presente y futuro&#46; An Pediatr &#40;Barc&#41;&#46; 2016&#59;85&#58;59&#8211;60&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nuevas estrategias terap&#233;uticas para el neuroblastoma basadas en los micro-RNA"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Boloix"
                            1 => "L&#46; Par&#237;s-Coderch"
                            2 => "A&#46; Soriano"
                            3 => "J&#46; Roma"
                            4 => "S&#46; Gallego"
                            5 => "J&#46; S&#225;nchez de Toledo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "An Pediatr &#40;Barc&#41;"
                        "fecha" => "2016"
                        "volumen" => "85"
                        "paginaInicial" => "109&#46;e1"
                        "paginaFinal" => "109&#46;e6"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Driving CAR-T cells forward"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "H&#46;J&#46; Jackson"
                            1 => "S&#46; Rafiq"
                            2 => "R&#46;J&#46; Brentjens"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/nrclinonc.2016.36"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nat Rev Clin Oncol"
                        "fecha" => "2016"
                        "volumen" => "13"
                        "paginaInicial" => "370"
                        "paginaFinal" => "383"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27000958"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Minimal disseminated disease in pediatric non-Hodgkin lymphoma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "L&#46; Mussolin"
                            1 => "A&#46; Rosolen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Carcinog Mutagen"
                        "fecha" => "2013"
                        "volumen" => "5"
                        "paginaInicial" => "1"
                        "paginaFinal" => "2"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Paciente cr&#237;tico onco-hematol&#243;gico&#46; &#191;Hacemos lo que deber&#237;amos hacer&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46; Garc&#237;a-Salido"
                            1 => "M&#46; Nieto-Moro"
                            2 => "M&#46;I&#46; Iglesias-Bouzas"
                            3 => "M&#46; Gonz&#225;lez-Vicent"
                            4 => "A&#46; Serrano-Gonz&#225;lez"
                            5 => "J&#46; Casado-Flores"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "An Pediatr"
                        "fecha" => "2016"
                        "volumen" => "85"
                        "paginaInicial" => "61"
                        "paginaFinal" => "69"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "European survey on standards of care in pediatric oncology centres"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;R&#46; Kowalczyk"
                            1 => "M&#46; Samardakiewicz"
                            2 => "K&#46; Pritchard-Jones"
                            3 => "R&#46; Ladenstein"
                            4 => "S&#46; Essiaf"
                            5 => "E&#46; Fitzgerald"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ejca.2016.03.073"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Cancer"
                        "fecha" => "2016"
                        "volumen" => "61"
                        "paginaInicial" => "11"
                        "paginaFinal" => "19"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27131152"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/23412879/0000008500000002/v1_201607230332/S2341287916300862/v1_201607230332/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "25501"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Editorial"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/23412879/0000008500000002/v1_201607230332/S2341287916300862/v1_201607230332/en/main.pdf?idApp=UINPBA00005H&text.app=https://analesdepediatria.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287916300862?idApp=UINPBA00005H"
]
Article information
ISSN: 23412879
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 13 9 22
2024 October 63 40 103
2024 September 52 27 79
2024 August 60 53 113
2024 July 63 32 95
2024 June 60 25 85
2024 May 45 42 87
2024 April 54 29 83
2024 March 43 28 71
2024 February 47 32 79
2024 January 32 18 50
2023 December 22 14 36
2023 November 28 33 61
2023 October 31 26 57
2023 September 21 19 40
2023 August 26 14 40
2023 July 33 40 73
2023 June 33 25 58
2023 May 38 18 56
2023 April 39 30 69
2023 March 31 24 55
2023 February 29 11 40
2023 January 23 25 48
2022 December 38 30 68
2022 November 44 26 70
2022 October 46 39 85
2022 September 47 30 77
2022 August 49 44 93
2022 July 39 42 81
2022 June 58 32 90
2022 May 80 47 127
2022 April 76 23 99
2022 March 116 64 180
2022 February 105 33 138
2022 January 80 42 122
2021 December 56 51 107
2021 November 74 42 116
2021 October 121 65 186
2021 September 56 61 117
2021 August 72 50 122
2021 July 56 37 93
2021 June 60 47 107
2021 May 78 38 116
2021 April 197 65 262
2021 March 109 34 143
2021 February 63 19 82
2021 January 69 27 96
2020 December 60 24 84
2020 November 59 22 81
2020 October 44 18 62
2020 September 33 20 53
2020 August 49 18 67
2020 July 50 30 80
2020 June 45 18 63
2020 May 62 18 80
2020 April 32 14 46
2020 March 26 12 38
2020 February 29 10 39
2020 January 25 13 38
2019 December 31 13 44
2019 November 33 12 45
2019 October 29 10 39
2019 September 36 9 45
2019 August 20 22 42
2019 July 33 13 46
2019 June 14 8 22
2019 May 39 20 59
2019 April 51 15 66
2019 March 32 17 49
2019 February 26 14 40
2019 January 30 21 51
2018 December 47 25 72
2018 November 105 21 126
2018 October 116 17 133
2018 September 47 12 59
2018 August 2 0 2
2018 July 1 0 1
2018 June 3 0 3
2018 May 6 0 6
2018 April 40 0 40
2018 March 29 0 29
2018 February 32 0 32
2018 January 19 0 19
2017 December 16 0 16
2017 November 19 0 19
2017 October 18 0 18
2017 September 15 0 15
2017 August 17 0 17
2017 July 20 1 21
2017 June 27 11 38
2017 May 25 13 38
2017 April 29 25 54
2017 March 11 4 15
2017 February 12 14 26
2017 January 6 6 12
2016 December 19 20 39
2016 November 41 21 62
2016 October 30 23 53
2016 September 48 9 57
2016 August 78 25 103
2016 July 21 9 30
Show all

Follow this link to access the full text of the article

Idiomas
Anales de Pediatría (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?